The global aspirin drug market is poised for substantial growth over the next decade, with its value expected to increase ...

Bayer’s hot flash drug candidate has hit the mark in a phase 3 breast cancer trial, potentially positioning the German drugmaker to get the jump on Astellas’ rival drug Veozah. Astellas won ...